Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-09-19 Sale | 2022-09-21 8:01 pm | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 4,272 | $1.0697 | $4,570 | 39,061 (Direct) | View |
2022-05-17 Purchase | 2022-05-19 7:43 pm | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 10,000 | $0.8228 | $8,228 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-03-01 Option Award | 2023-03-03 5:23 pm | N/A 2033-02-28 | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 225,000 | $0 | 225,000 (Direct) | View |
2022-09-14 Option Award(A) | 2022-09-21 7:55 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 33,333 | $0 | 43,333 (Direct) | View |
2022-09-14 Option Award | 2022-09-16 7:26 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 25,000 | $0 | 35,000 (Direct) | View |
2022-02-07 Option Award | 2022-02-09 5:10 pm | N/A 2032-02-06 | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 485,000 | $0 | 485,000 (Direct) | View |
Ownership | 2022-02-09 5:08 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 0 | $0 | 0 (Direct) | View |